Jeffrey Miller, MD
Hematology · Minneapolis, MNNPI 1053497198
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $31,848 of the $41,287 with a category attached, or 77.1%. 9 manufacturers reported payments, led by Sanofi at 43.3% of the total. Reporting peaked in 2023 at $23,451 and has fallen 83.3% since, to $3,913 in 2025.
Across 32 payments — averaging $1290.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$18K
- Regeneron$10K
- Sanofi US Services Inc.$5K
- Gilead$4K
- Chugai Pharmaceutical Co., Ltd.$2K
- Genentech, Inc.$2K
- plus $811 from 3 others
What the payments were for
- Consulting fees$31,84877%
- Speaking & faculty fees$5,17813%
- Travel & lodging$3,5769%
- Food & beverage$6652%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 11 | $17,889 |
| Regeneron | 12 | $10,017 |
| Sanofi US Services Inc. | 1 | $5,178 |
| Gilead | 3 | $3,913 |
| Chugai Pharmaceutical Co., Ltd. | 1 | $1,980 |
| Genentech, Inc. | 1 | $1,500 |
| Bristol Myers Squibb | 1 | $750 |
| GSK | 1 | $41 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SARCLISA$4,495
How this compares
$41,287 in reported general payments places this provider in the 85th percentile of 111 hematology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Minneapolis
- Shernan HoltanMinneapolis$53K
- Robert HebbelMinneapolis$48K
- Fiona HeMinneapolis$14K
- Michael LindenMinneapolis$6K
- Mark JuckettMinneapolis$4K
- Lucas Gerhard Peter MaahsMinneapolis$1K
- Sanjal DesaiMinneapolis$391
- Shaji KumarRochester$452K
- Yi LinRochester$365K
- David DingliRochester$299K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.